CD79A and myeloid sarcoma: Yacyshynet al. [33] demonstrated that 25% of MS patients under study had increased intestinal permeability, while Reichelt and Jensen [34] observed the presence of IgA and IgG antibodies against gliadin and gluten in MS patients.